HBV vaccination status among healthcare workers: A cross-sectional study.
Vaccination
blood-borne viruses
epidemiology
Journal
Journal of infection prevention
ISSN: 1757-1774
Titre abrégé: J Infect Prev
Pays: England
ID NLM: 101469725
Informations de publication
Date de publication:
Jan 2020
Jan 2020
Historique:
received:
06
11
2018
accepted:
28
07
2019
entrez:
8
2
2020
pubmed:
8
2
2020
medline:
8
2
2020
Statut:
ppublish
Résumé
The development of a vaccine against hepatitis B virus (HBV) is one of the improvements in strategy prevention during the last decades. To evaluate HBV-related vaccine status in healthcare workers (HCW) exposed to biological risk. The serum markers for HBV were collected from HCWs in two tertiary care hospitals in Naples (Italy). Multivariate statistical analysis was then performed to identify associated factors linked to the long-term immunogenicity of the HCWs. All HBV vaccinated individuals were screened for whole marker patterns; all were HBsAg/anti-HBc negative. Of individuals, 20% had an anti-HB antibody titre < 10 IU/L. Multivariate statistical analysis highlighted that women were more protected than men (73.6% vs. 26.4%, Our data support the evidence of a strong immunogenicity against HBV, assessed through the circulating antibody titre, when prophylactic vaccination is conducted in non-infantile age, particularly for women. The outcome of the study supports the central role of occupational physicians within the hospital districts in terms of primary prevention and maximum protection of HCWs.
Identifiants
pubmed: 32030100
doi: 10.1177/1757177419873043
pii: 10.1177_1757177419873043
pmc: PMC6978564
doi:
Types de publication
Journal Article
Langues
eng
Pagination
23-27Informations de copyright
© The Author(s) 2019.
Déclaration de conflit d'intérêts
Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Références
Infect Control Hosp Epidemiol. 2008 Dec;29(12):1189-91
pubmed: 18973454
World J Gastroenterol. 2016 Oct 21;22(39):8720-8734
pubmed: 27818588
Euro Surveill. 2005 Oct;10(10):260-4
pubmed: 16282641
J Occup Med Toxicol. 2015 Nov 04;10:41
pubmed: 26539242
MMWR Recomm Rep. 2013 Dec 20;62(RR-10):1-19
pubmed: 24352112
Vaccine. 2012 Mar 9;30(12):2212-9
pubmed: 22273662
MMWR Recomm Rep. 1997 Dec 26;46(RR-18):1-42
pubmed: 9427216
Hepat Mon. 2014 Sep 23;14(9):e22223
pubmed: 25368659
Lancet. 2005 Oct 15-21;366(9494):1379-84
pubmed: 16226616
Eur J Public Health. 2011 Jun;21(3):338-43
pubmed: 20817688
World J Gastroenterol. 2014 Jun 28;20(24):7635-43
pubmed: 24976701
BMC Res Notes. 2018 Dec 13;11(1):886
pubmed: 30545400
Vaccine. 2011 Oct 13;29(44):7835-41
pubmed: 21816197
J Ren Care. 2014 Sep;40(3):150-6
pubmed: 24650088
Vaccine. 2013 Mar 25;31(13):1696-700
pubmed: 23384750
N Engl J Med. 1997 Dec 11;337(24):1733-45
pubmed: 9392700